查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014685

胃肠道支架市场：2026-2032年全球市场预测（按产品类型、材料、置入方法、应用、最终用户和分销管道划分）

Gastrointestinal Stents Market by Product Type, Material, Placement Method, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胃肠道支架市场价值将达到 4.899 亿美元，到 2026 年将成长至 5.2143 亿美元，到 2032 年将达到 7.4426 亿美元，复合年增长率为 6.15%。

主要市场统计数据
基准年 2025 4.899亿美元
预计年份：2026年 5.2143亿美元
预测年份 2032 7.4426亿美元
复合年增长率 (%) 6.15%

简要概述影响胃肠道支架短期策略决策的临床因素、技术进步和商业性因素。

本执行摘要概述了胃肠道支架的最新发展趋势，重点阐述了影响采购和研发决策的临床需求、技术驱动因素和商业性考量。内视镜和透视技术的进步，以及支架材料和设计的不断改进，已经改变了临床医生的选择偏好和手术流程。同时，不断变化的支付方期望和医院供应链策略也在影响产品的评估和应用。

器械工程、混合手术方案和供应链重组的突破如何重塑胃肠道支架的临床应用和商业策略。

胃肠道支架领域正经历一场变革，这得益于器械工程技术的进步、手术流程的创新以及更一体化的病患诊疗路径。诸如个人化径向力分布、防移位功能和亲水涂层等设计改进，改变了临床医生对支架耐用性和易置性的预期。同时，结合内视镜和透视技术的混合手术路径的出现，拓展了支架的应用临床场景，进而影响采购规范和训练重点。

2025 年美国关税调整对胃肠道支架的采购、本地化生产和分销方式的实际影响。

关税和贸易政策的变化将对医疗设备资本财和耗材的流通产生重大影响，预计2025年美国的关税环境将为胃肠支架行业的相关人员带来一系列营运挑战和策略选择。关税调整会影响接收成本，进而影响医院、门诊中心和集团采购组织的采购决策。采购团队可能会透过供应商多元化、转向区域製造合作伙伴或重新谈判合约以加入关税转嫁条款来应对。

将产品类型、材料、植入方法、最终用户、应用和分销管道与临床引进和采购因素联繫起来的详细細項分析。

清晰了解细分市场对于使产品开发和商业策略与临床及组织需求保持一致至关重要。根据产品类型，市场可细分为塑胶支架和自膨式金属支架。自膨式金属支架可进一步细分为涂层自膨式金属支架和非涂层自膨式金属支架。这种区分至关重要，因为塑胶支架和金属支架之间，以及涂层支架和非涂层支架之间，手术方式的选择、预期植入时间和併发症发生率均有显着差异。按材料划分，市场可分为金属和塑胶。这会影响製造过程、灭菌方法以及临床医生根据所治疗的解剖部位和病理情况而做出的选择。依植入方法划分，市场可分为内视镜/透视辅助植入、内视镜植入和透视辅助植入。每种植入方法都有其独特的训练要求、对医疗设备的依赖性，以及对术前术后工作流程的影响，这些都会影响其采用率。

透过对美洲、欧洲、中东和非洲以及亚太地区的比较区域分析，揭示了需求和投资优先事项的决定因素。

区域趋势影响胃肠支架相关人员如何确定投资优先顺序、建立分销网络以及与临床医生互动。在美洲，整合的医院系统、集中采购架构以及对实证医学应用的重视影响着市场需求模式。这有利于那些能够证明其临床疗效可靠并提供整合服务模式的供应商。相较之下，欧洲、中东和非洲地区的管理体制架构和采购方式各不相同，各国的报销政策和区域性生产奖励对于市场新进业者而言既可能是障碍，也可能是机会。在这些地区，个人临床检验和灵活的商业条款往往是决定性因素。

製造商如何将平台模组化、临床证据的创建和策略伙伴关係关係结合起来，以确保在临床环境中得到应用并获得采购交易？

胃肠道支架领域的竞争格局由产品差异化、临床证据策略、策略伙伴关係共同构成​​。领先的製造商正日益重视模组化平台，使其能够适应不同的解剖部位和适应症，从而提高规模经济效益并简化医护人员的培训。与医疗设备配件製造商、诊断公司和影像技术供应商的合作也十分普遍，从而能够提供兼顾手术效率和临床疗效的捆绑式解决方案。此外，一些公司正在加强上市后监测和真实世界数据（RWE）项目，以支持扩大适应症范围并与支付者进行谈判。

可操作的、高优先顺序的策略措施，旨在帮助製造商、供应商和临床相关人员提高韧性、采用率和可衡量的价值交付。

产业相关人员应采取一系列切实可行的措施来增强韧性、差异化优势和临床影响力。首先，将产品开发与手术流程（特别是混合内视镜和透视方法）结合，可以最大限度地减少培训负担和资本投入，从而降低推广门槛。其次，投资于真实世界数据 (REW) 和上市后调查计画，有助于与保险公司进行咨询并拓展临床适应症，从而促进产品纳入医疗保险范围。第三，探索供应链方案，包括本地组装和零件采购，可以降低关税和物流风险，同时缩短前置作业时间。

高度透明、多方面的调查方法，结合临床访谈、文献分析和供应链检验，为可靠的结论提供了支持。

本报告的结论是基于严谨的多源调查方法，旨在确保提供可操作的洞见和透明的可追溯性。主要研究包括对临床负责人、采购专家和医疗设备公司高阶主管进行结构化访谈，以了解他们对手术选择标准、采购行为和服务期望的实际观点。次要研究则利用同行评审的临床文献、监管文件和公开的企业资讯披露，来阐释技术趋势和证据要求。

一份综合总结，重点阐述相关人员为应对胃肠道支架的临床、商业性和监管变化而采取的策略重点。

总而言之，胃肠道支架市场面临着多种因素交织的复杂压力，包括临床对微创和耐用解决方案的需求、供应商围绕平台适应性和循证医学证据的竞争，以及关税变化和区域监管差异等外部因素。能够将严格的临床检验、灵活的分销模式和区域定制的供应链策略相结合的相关人员，将更有利于确保产品的永续应用。此外，在临床疗效和医疗总成本之间取得平衡至关重要的情况下，对临床医生培训、上市后证据和整合服务交付的投资，将在采购决策中发挥关键作用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：胃肠道支架市场：依产品类型划分

  • 塑胶支架
  • 自膨式金属支架
    • 覆膜自膨式金属支架
    • 无涂层自膨式金属支架

第九章：胃肠道支架市场：依材料分类

  • 金属
  • 塑胶

第十章：以置入方式分類的胃肠道支架市场

  • 采用内视镜和透视相结合的方法进行定位
  • 内视镜置入
  • 透视定位

第十一章：胃肠道支架市场：依应用领域划分

  • 胆道阻塞
  • 结肠狭窄
  • 十二指肠阻塞
  • 食道狭窄
  • 胃出口阻塞

第十二章：胃肠道支架市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十三章：胃肠支架市场：依通路划分

  • 直销
  • 透过分销商销售

第十四章：胃肠道支架市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：胃肠道支架市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：胃肠道支架市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国胃肠道支架市场

第十八章：中国胃肠支架市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Arterial Remodeling Technologies SA
  • Arterius Ltd
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • JW Medical Systems LTD
  • Kaneka Corporation
  • KLS Martin Group
  • Kyoto Medical Planning Co. Ltd.
  • Medtronic Plc
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • OrbusNeich Medical
  • Q3 Medical Devices Limited.
  • Reva Medical
  • SafeGuard Surgical, Inc.
  • Smith & Nephew Plc
  • Stryker Corporation
  • Syntellix AG
  • Terumo Corporation
Product Code: MRR-437E9896A501

The Gastrointestinal Stents Market was valued at USD 489.90 million in 2025 and is projected to grow to USD 521.43 million in 2026, with a CAGR of 6.15%, reaching USD 744.26 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 489.90 million
Estimated Year [2026] USD 521.43 million
Forecast Year [2032] USD 744.26 million
CAGR (%) 6.15%

A concise orientation to gastrointestinal stent clinical drivers, technological progress, and commercial forces shaping near-term strategic decisions

This executive summary introduces the contemporary landscape of gastrointestinal stents, framing clinical imperatives, technological drivers, and commercial considerations that underpin procurement and development decisions. Advances in endoscopic and fluoroscopic techniques, coupled with iterative improvements in stent materials and designs, have reshaped clinician preferences and procedural workflows. At the same time, shifting payer expectations and hospital supply chain strategies are influencing how products are evaluated and adopted.

Clinically, the emphasis on minimally invasive solutions for obstructive pathologies and strictures has heightened reliance on stenting as both a bridge to definitive therapy and a palliative measure. From a commercial perspective, manufacturers and suppliers are navigating a convergence of innovation pressure and cost containment, which requires more nuanced product differentiation and evidence generation. This introduction summarizes the principal forces that will be explored in depth throughout the report, including procedural placement methods, material selection, end-user dynamics, and distribution channels, all of which coalesce to determine how stakeholders prioritize investments and partnerships going forward.

How device engineering breakthroughs, hybrid procedural protocols, and supply chain realignments are reshaping clinical use and commercial strategies in gastrointestinal stents

The landscape for gastrointestinal stents is undergoing transformative shifts driven by advances in device engineering, procedural innovation, and a more integrated approach to patient pathways. Design improvements such as tailored radial force profiles, anti-migration features, and hydrophilic coatings have changed clinician expectations for durability and deliverability. Simultaneously, the emergence of hybrid procedural pathways that combine endoscopic and fluoroscopic techniques has expanded the range of clinical scenarios where stents are viable, thereby influencing procurement specifications and training priorities.

In addition, supply chain realignments-prompted by regional manufacturing diversification and strategic partnerships between device makers and hospital systems-are altering time-to-procure dynamics and inventory management. Regulatory scrutiny around post-market surveillance and clinical evidence has intensified, leading manufacturers to invest in robust clinical data capture and real-world evidence strategies. Lastly, digital health adjuncts such as procedure planning software and remote monitoring capabilities are beginning to intersect with stent therapies, enabling new services and bundled care models that could reshape reimbursement discussions and provider contracting.

Practical implications of United States tariff adjustments in 2025 on procurement, manufacturing localization, and distribution approaches for gastrointestinal stents

Policy shifts in tariffs and trade policy can exert outsized influence on capital and consumable medical device flows, and the United States tariff environment anticipated for 2025 presents a set of operational challenges and strategic choices for stakeholders in gastrointestinal stents. Tariff adjustments affect landed costs, which in turn influence purchasing decisions by hospitals, ambulatory centers, and group purchasing organizations. Procurement teams may respond by diversifying supplier bases, shifting toward regional manufacturing partners, or renegotiating contracts to include tariff pass-through clauses.

Moreover, tariff-related cost pressure often accelerates evaluation of distribution models and inventory strategies. For some suppliers, increased import duties create incentives to localize key components or to establish assembly operations closer to major end markets. At the same time, providers may optimize formulary lists and standardize on stent platforms that balance clinical performance with total cost of ownership. Finally, policymakers' communication and timelines for tariff implementation materially affect contract renewals and capital planning, so stakeholders should build scenario-based procurement and manufacturing contingencies that allow rapid adaptation to regulatory changes.

Deep segmentation analysis linking product type, material, placement method, end-user, application and distribution channel to clinical adoption and procurement drivers

Segment-level clarity is essential for aligning product development and commercial strategies with clinical and institutional needs. Based on Product Type, the market is examined across Plastic Stent and Self-Expandable Metallic Stent, with the Self-Expandable Metallic Stent further analyzed across Covered Self-Expandable Metallic Stent and Uncovered Self-Expandable Metallic Stent; this differentiation matters because procedural selection, expected dwell time, and complication profiles vary markedly between plastic devices and metallic constructs, and between covered and uncovered variants. Based on Material, the market is studied across Metal and Plastic, which has implications for manufacturing processes, sterilization pathways, and clinician preference depending on targeted anatomy and pathology. Based on Placement Method, the market is studied across Combined Endoscopic Fluoroscopic Placement, Endoscopic Placement, and Fluoroscopic Placement, and each placement method carries distinct training requirements, capital equipment dependencies, and peri-procedural workflow impacts that influence adoption rates.

Based on End User, the market is studied across Ambulatory Surgical Center, Clinic, and Hospital, and differences in procedural volumes, reimbursement models, and facility resources shape purchasing priorities and stocking practices. Based on Application, the market is studied across Biliary Obstruction, Colorectal Stricture, Duodenal Obstruction, Esophageal Stricture, and Gastric Outlet Obstruction, and clinical outcomes, patient comorbidities, and interdisciplinary care pathways vary by indication, informing evidence needs and labeling strategies. Finally, based on Distribution Channel, the market is studied across Direct Sales and Distributor Sales, each of which presents different margin structures, service expectations, and opportunities for value-added clinical support. Taken together, these segmentation dimensions illuminate where clinical need, purchasing behavior, and differentiation opportunities intersect, enabling stakeholders to prioritize development and commercial investments with greater precision.

Comparative regional intelligence across Americas, Europe Middle East & Africa, and Asia-Pacific highlighting demand determinants and investment priorities

Regional dynamics shape how gastrointestinal stent stakeholders prioritize investments, structure distribution, and engage with clinicians. In the Americas, demand patterns are influenced by consolidated hospital systems, centralized procurement frameworks, and an emphasis on evidence-based adoption; these conditions favor suppliers who can demonstrate robust clinical outcomes and offer integrated service models. In contrast, Europe, Middle East & Africa exhibits a spectrum of regulatory regimes and procurement approaches, where national reimbursement policies and local manufacturing incentives can create both barriers and opportunities for market entrants. In this region, tailored clinical validation and flexible commercial terms often prove decisive.

Asia-Pacific presents a heterogeneous landscape driven by rapid capacity expansion in tertiary care, varying regulatory pathways, and a growing focus on minimally invasive therapies. Manufacturers that invest in regional clinical partnerships, local training programs, and supply chain footholds tend to gain traction. Across all regions, differences in hospital infrastructure, availability of specialized proceduralists, and payer arrangements influence where innovation is first adopted and how product portfolios are prioritized. Therefore, regional go-to-market strategies must reconcile global product standards with local clinical and commercial realities to achieve sustainable adoption.

How manufacturers are combining platform modularity, clinical evidence generation, and strategic partnerships to secure clinical adoption and procurement wins

Competitive dynamics in gastrointestinal stents combine product differentiation, clinical evidence strategies, and strategic partnerships. Leading manufacturers increasingly prioritize modular platforms that can be adapted across anatomical sites and indications, thereby improving economies of scale and simplifying provider training. Partnerships with device accessory makers, diagnostic companies, and imaging technology vendors are also prevalent, enabling bundled solutions that address procedural efficiency and clinical outcomes. Moreover, some firms are strengthening post-market surveillance and real-world evidence programs to support labeling extensions and payer negotiations.

Innovation is frequently accompanied by targeted go-to-market plays such as center-of-excellence programs, hands-on clinician training, and outcomes-based contracts that align incentives across stakeholders. Smaller, specialized firms often focus on niche applications or novel coatings and delivery mechanisms to differentiate from incumbents, while larger manufacturers leverage distribution networks and service capabilities to secure hospital formularies. In aggregate, competitive positioning is less about single-product superiority and more about demonstrating total clinical and operational value in a way that resonates with procurement committees, clinicians, and payers.

Practical, prioritized strategic moves for manufacturers, suppliers, and clinical stakeholders to enhance resilience, adoption, and measurable value delivery

Industry participants should pursue a set of actionable measures to strengthen resilience, differentiation, and clinical impact. First, aligning product development with procedural workflows-particularly hybrid endoscopic-fluoroscopic approaches-will reduce barriers to adoption by minimizing training friction and capital expenditure. Second, investing in real-world evidence and post-market surveillance programs will support payer discussions and broaden clinical labeling, thereby improving formulary acceptance. Third, evaluating supply chain options that include regional assembly or component sourcing can mitigate tariff and logistics risks while shortening lead times.

Additionally, commercial teams should tailor channel strategies to end-user profiles, prioritizing direct-sales engagement for high-volume hospital systems and distributor partnerships where broad geographic reach and local regulatory know-how are required. Clinical education programs that combine simulation, proctoring, and outcomes tracking can accelerate clinician confidence and procedural volume. Finally, consider pursuing bundled service offerings that integrate devices with planning tools, training, and post-procedural follow-up to articulate a compelling total-cost-and-outcome value proposition to providers and payers alike.

A transparent multi-source research methodology integrating clinical interviews, literature synthesis, and supply chain verification to underpin trustworthy conclusions

The report's conclusions are underpinned by a rigorous, multi-source research methodology designed to ensure actionable insights and transparent traceability. Primary research included structured interviews with clinical leaders, procurement specialists, and device company executives to capture practical perspectives on procedural preferences, purchasing behavior, and service expectations. Secondary research drew on peer-reviewed clinical literature, regulatory documentation, and publicly available company disclosures to contextualize technology trends and evidence requirements.

Analytical steps included cross-validation of interview findings against published clinical outcomes and procedural guidelines, as well as supply chain verification through distributor and logistics partner consultations. The synthesis emphasizes reproducibility by documenting assumptions and evidence sources, and it applies qualitative scenario analysis to examine policy and supply-chain contingencies. Wherever possible, assertions were corroborated by multiple independent sources to reduce single-source bias and to provide a defensible basis for strategic recommendations.

Consolidated takeaways emphasizing strategic priorities for stakeholders to navigate clinical, commercial, and regulatory shifts in gastrointestinal stents

In conclusion, the gastrointestinal stent landscape is characterized by converging pressures: clinical demand for minimally invasive, durable solutions; vendor competition centered on platform adaptability and evidence generation; and external forces such as tariff changes and regional regulatory variability. Stakeholders that combine disciplined clinical validation, flexible distribution models, and localized supply chain strategies will be best positioned to capture sustained adoption. Moreover, investments in clinician training, post-market evidence, and integrated service offerings will prove decisive in environments where procurement decisions balance clinical outcomes against total cost of care.

Looking ahead, successful organizations will be those that translate technical innovation into demonstrated procedural advantages and operational efficiencies while maintaining agility in sourcing and commercialization. By prioritizing these strategic levers, manufacturers, providers, and distributors can navigate shifting policy landscapes and evolving clinical pathways to deliver better patient outcomes and stronger commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Stents Market, by Product Type

  • 8.1. Plastic Stent
  • 8.2. Self-Expandable Metallic Stent
    • 8.2.1. Covered Self-Expandable Metallic Stent
    • 8.2.2. Uncovered Self-Expandable Metallic Stent

9. Gastrointestinal Stents Market, by Material

  • 9.1. Metal
  • 9.2. Plastic

10. Gastrointestinal Stents Market, by Placement Method

  • 10.1. Combined Endoscopic Fluoroscopic Placement
  • 10.2. Endoscopic Placement
  • 10.3. Fluoroscopic Placement

11. Gastrointestinal Stents Market, by Application

  • 11.1. Biliary Obstruction
  • 11.2. Colorectal Stricture
  • 11.3. Duodenal Obstruction
  • 11.4. Esophageal Stricture
  • 11.5. Gastric Outlet Obstruction

12. Gastrointestinal Stents Market, by End User

  • 12.1. Ambulatory Surgical Center
  • 12.2. Clinic
  • 12.3. Hospital

13. Gastrointestinal Stents Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor Sales

14. Gastrointestinal Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Gastrointestinal Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Gastrointestinal Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Gastrointestinal Stents Market

18. China Gastrointestinal Stents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Arterial Remodeling Technologies SA
  • 19.7. Arterius Ltd
  • 19.8. B. Braun Melsungen AG
  • 19.9. BIOTRONIK SE & Co. KG
  • 19.10. Boston Scientific Corporation
  • 19.11. Elixir Medical Corporation
  • 19.12. JW Medical Systems LTD
  • 19.13. Kaneka Corporation
  • 19.14. KLS Martin Group
  • 19.15. Kyoto Medical Planning Co. Ltd.
  • 19.16. Medtronic Plc
  • 19.17. Meril Life Sciences Pvt. Ltd.
  • 19.18. Microport Scientific Corporation
  • 19.19. OrbusNeich Medical
  • 19.20. Q3 Medical Devices Limited.
  • 19.21. Reva Medical
  • 19.22. SafeGuard Surgical, Inc.
  • 19.23. Smith & Nephew Plc
  • 19.24. Stryker Corporation
  • 19.25. Syntellix AG
  • 19.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COVERED SELF-EXPANDABLE METALLIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COVERED SELF-EXPANDABLE METALLIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COVERED SELF-EXPANDABLE METALLIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY UNCOVERED SELF-EXPANDABLE METALLIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY UNCOVERED SELF-EXPANDABLE METALLIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY UNCOVERED SELF-EXPANDABLE METALLIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COMBINED ENDOSCOPIC FLUOROSCOPIC PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COMBINED ENDOSCOPIC FLUOROSCOPIC PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COMBINED ENDOSCOPIC FLUOROSCOPIC PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ENDOSCOPIC PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ENDOSCOPIC PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ENDOSCOPIC PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY FLUOROSCOPIC PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY FLUOROSCOPIC PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY FLUOROSCOPIC PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLORECTAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLORECTAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLORECTAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GASTRIC OUTLET OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GASTRIC OUTLET OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GASTRIC OUTLET OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 143. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 145. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 167. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 169. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 175. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 177. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)